• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        Assessment of Insulin-Like Growth Factors and Mutagen Sensitivity as Predictors of Lung Cancer Risk

        互联网

        1309
        Insulin-like growth factors (IGFs) are mitogenic peptide hormones involved in the regulation of cell proliferation, differentiation, transformation, and apoptosis. The members of the IGF family include two types of peptides (IGF-1 and IGF-2), two types of cell membrane receptors (IGF-1R and IGF-2R), and six binding proteins (IGFBP1-6) (1 ,2 ). This family of growth factors has several important functions. IGF-mediated activation of the IGF-1 receptor stimulates the signal transduction pathway involving MAP kinase (i.e., mitogen-activated protein kinase) and increases the expression of cyclin D1, which accelerates cell-cycle progression from G1 to S phase (2 ,3 ). IGFs also suppress programmed cell death by increasing the synthesis of Bcl proteins and inhibiting that of Bax proteins (4 ,5 ). Furthermore, IGFs counteract the actions of many antiproliferative molecules, such as retinoic acid. IGFBPs normally inhibit the mitogenic action of IGFs by blocking the binding of IGFs to their receptor (6 ). Blocking the interaction between IGFs and their receptors can abolish IGF-stimulated proliferation of lung cancer cells (7 ,8 ). IGFBP-3 is the principal IGFBP in the circulation.
        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序